Home - BrYet

Our Mission Is to Be the First to Develop Fully Curative Approaches to Metastatic Cancer.

We are focused on developing drugs for the treatment and cure of otherwise incurable cancers using multi-component therapeutics to target transport phenotypes.

Learn More

men in a laboratory microscope with microscope slide in hand

N

Unprecedented Efficacy

Unprecedented efficacy in treating metastatic cancer has been demonstrated in preclinical trials.

N

Peer-reviewed Research

Our research has been published in leading peer-reviewed scientific journals.

N

Patent Protected

Protected by a strong patent portfolio of our own intellectual property, and some licensed from Houston Methodist Research Institute & University of Texas Health Science Center at Houston.

About Us

BrYet is a privately-owned biotech company focused on the discovery and development of first-in-class therapies for primary or metastatic cancers of the lungs and liver.